Last Updated: August 3, 2026

ULTRAVIST 300 IN PLASTIC CONTAINER Drug Patent Profile

✉ Email this page to a colleague

When do Ultravist 300 In Plastic Container patents expire, and when can generic versions of Ultravist 300 In Plastic Container launch?

Ultravist 300 In Plastic Container is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in ULTRAVIST 300 IN PLASTIC CONTAINER is iopromide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopromide profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ULTRAVIST 300 IN PLASTIC CONTAINER?
What are the global sales for ULTRAVIST 300 IN PLASTIC CONTAINER?
What is Average Wholesale Price for ULTRAVIST 300 IN PLASTIC CONTAINER?

Summary for ULTRAVIST 300 IN PLASTIC CONTAINER

US Patents:	0
Applicants:	1
NDAs:	1

US Patents and Regulatory Information for ULTRAVIST 300 IN PLASTIC CONTAINER

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Hlthcare	ULTRAVIST 300 IN PLASTIC CONTAINER	iopromide	INJECTABLE;INJECTION	020220-005	Nov 18, 2008		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for ULTRAVIST 300 IN PLASTIC CONTAINER

See the table below for patents covering ULTRAVIST 300 IN PLASTIC CONTAINER around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Austria	1061		⤷ Start Trial
Australia	529565		⤷ Start Trial
Australia	5627280		⤷ Start Trial
Canada	1130316	DIAMIDES D'ACIDE ISOPHTALIQUE TRI-IODES UTILISES COMME AGENTS DE CONTRASTE NON IONIQUES POUR RAYONS X (TRI-IODATED ISOPHTHALIC ACID DIAMIDES AS NON-IONIC X-RAY CONTRAST AGENTS)	⤷ Start Trial
Czechoslovakia	226408	METHOD OF PREPARING TRIIODINATED DIAMIDES OF ISOPHTALIC ACID	⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.